Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rap guanine nucleotide exchange factor-like 1 is a predicted guanine nucleotide exchange factor (GEF) enzyme, involved in signal transduction by enabling the exchange of GDP for GTP on Ras-related small GTPases, primarily influencing the Ras protein pathway. It is a membrane-associated protein, with activities relating to cellular signaling and regulation, and has documented associations with certain neurological diseases, including autosomal dominant deafness and leukoencephalopathy with vanishing white matter. The gene is not currently a well-validated drug target for any approved therapeutic agents, nor are there recognized biomarkers or major safety issues directly attributed to its modulation[2][5].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rap guanine nucleotide exchange factor-like 1 (RAPGEFL1).